Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Pierre-Antoine Gourraud, PhD

    TitleAssistant Adjunct Professor
    SchoolUCSF School of Medicine
    Address675 Nelson Rising Lane
    San Francisco CA 94158
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California, San FranciscoPostdoctoral Studies Graduate Division

      Collapse Overview 
      Collapse Interests
      Multiple Sclerosis, Biostatistics, Immunogenomics, MHC, Genetic epidemiology, Magnetic Resonance Imaging, HLA

      Collapse ORNG Applications 
      Collapse In The News
      Collapse NIH Awarded Grants
      Collapse Global Health
      Collapse Featured Videos

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Khankhanian P, Matsushita T, Madireddy L, Lizée A, Din L, Moré JM, Gourraud PA, Hauser SL, Baranzini SE, Oksenberg JR. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews. BMC Med Genet. 2015; 16:55.
        View in: PubMed
      2. Khankhanian P, Gourraud PA, Lizee A, Goodin DS. Haplotype-based approach to known MS-associated regions increases the amount of explained risk. J Med Genet. 2015 Sep; 52(9):587-94.
        View in: PubMed
      3. Laurent C, Do C, Gourraud PA, de Paiva GR, Valmary S, Brousset P. Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases. Medicine (Baltimore). 2015 Jun; 94(25):e987.
        View in: PubMed
      4. Pappas DJ, Gourraud PA, Le Gall C, Laurent J, Trounson A, DeWitt N, Talib S. Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population. Stem Cells Transl Med. 2015 May; 4(5):413-8.
        View in: PubMed
      5. Hadjixenofontos A, Gourraud PA, Bakthavachalam V, Foco L, Ticca A, Bitti P, Pastorino R, Bernardinelli L, McCauley JL. Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia. Mult Scler. 2015 Oct; 21(11):1396-403.
        View in: PubMed
      6. Isobe N, Madireddy L, Khankhanian P, Matsushita T, Caillier SJ, Moré JM, Gourraud PA, McCauley JL, Beecham AH. An ImmunoChip study of multiple sclerosis risk in African Americans. Brain. 2015 Jun; 138(Pt 6):1518-30.
        View in: PubMed
      7. Khankhanian P, Din L, Caillier SJ, Gourraud PA, Baranzini SE. SNP imputation bias reduces effect size determination. Front Genet. 2015; 6:30.
        View in: PubMed
      8. Gourraud PA, Pappas DJ, Baouz A, Balère ML, Garnier F, Marry E. High-resolution HLA-A, HLA-B, and HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor Registry. Hum Immunol. 2015 May; 76(5):381-4.
        View in: PubMed
      9. Pappas DJ, Tomich A, Garnier F, Marry E, Gourraud PA. Comparison of high-resolution human leukocyte antigen haplotype frequencies in different ethnic groups: Consequences of sampling fluctuation and haplotype frequency distribution tail truncation. Hum Immunol. 2015 May; 76(5):374-80.
        View in: PubMed
      10. Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain. 2015 Mar; 138(Pt 3):632-43.
        View in: PubMed
      11. Pino-Yanes M, Gignoux CR, Galanter JM, Levin AM, Campbell CD, Eng C, Huntsman S, Nishimura KK, Gourraud PA, Mohajeri K, O'Roak BJ, Hu D, Mathias RA, Nguyen EA, Roth LA, Padhukasahasram B, Moreno-Estrada A, Sandoval K, Winkler CA, Lurmann F, Davis A, Farber HJ, Meade K, Avila PC, Serebrisky D, Chapela R, Ford JG, Lenoir MA, Thyne SM, Brigino-Buenaventura E, Borrell LN, Rodriguez-Cintron W, Sen S, Kumar R, Rodriguez-Santana JR, Bustamante CD, Martinez FD, Raby BA, Weiss ST, Nicolae DL, Ober C, Meyers DA, Bleecker ER, Mack SJ, Hernandez RD, Eichler EE, Barnes KC, Williams LK, Torgerson DG, Burchard EG. Genome-wide association study and admixture mapping reveal new loci associated with total IgE levels in Latinos. J Allergy Clin Immunol. 2015 Jun; 135(6):1502-10.
        View in: PubMed
      12. Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL. Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Ann Neurol. 2014 Nov; 76(5):633-42.
        View in: PubMed PMC4214886
      13. Madbouly A, Gragert L, Freeman J, Leahy N, Gourraud PA, Hollenbach JA, Kamoun M, Fernandez-Vina M, Maiers M. Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments. Tissue Antigens. 2014 Sep; 84(3):285-92.
        View in: PubMed
      14. Gourraud PA, Khankhanian P, Cereb N, Yang SY, Feolo M, Maiers M, Rioux JD, Hauser S, Oksenberg J. HLA diversity in the 1000 genomes dataset. PLoS One. 2014; 9(7):e97282.
        View in: PubMed PMC4079705
      15. Gourraud PA, Balère ML, Faucher C, Loiseau P, Dormoy A, Marry E, Garnier F. HLA phenotypes of candidates for HSCT: comparing transplanted versus non-transplanted candidates, resulting in the predictive estimation of the probability to find a 10/10 HLA matched donor. Tissue Antigens. 2014 Jan; 83(1):17-26.
        View in: PubMed
      16. Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, Noble JA, Raj T. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet. 2013 Nov; 9(11):e1003926.
        View in: PubMed PMC3836799
      17. Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler. 2014 May; 20(6):660-8.
        View in: PubMed PMC4066985
      18. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013 Nov; 45(11):1353-60.
        View in: PubMed PMC3832895
      19. Eberhard HP, Madbouly AS, Gourraud PA, Balère ML, Feldmann U, Gragert L, Torres HM, Pingel J, Schmidt AH, Steiner D, van der Zanden HG, Oudshoorn M, Marsh SG, Maiers M, Müller CR. Comparative validation of computer programs for haplotype frequency estimation from donor registry data. Tissue Antigens. 2013 Aug; 82(2):93-105.
        View in: PubMed
      20. Isobe N, Damotte V, Lo Re V, Ban M, Pappas D, Guillot-Noel L, Rebeix I, Compston A, Mack T, Cozen W, Fontaine B, Hauser SL, Oksenberg JR, Sawcer S, Gourraud PA. Genetic burden in multiple sclerosis families. Genes Immun. 2013 Oct; 14(7):434-40.
        View in: PubMed PMC4102601
      21. Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, Maiers M, Spellman S, Cereb N, Yang S, Pando MJ, Piccio L, Cross AH, De Jager PL, Cree BA, Hauser SL, Oksenberg JR. Genetic risk variants in African Americans with multiple sclerosis. Neurology. 2013 Jul 16; 81(3):219-27.
        View in: PubMed PMC3770164
      22. Li M, Zhang H, Luo XJ, Gao L, Qi XB, Gourraud PA, Su B. Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population. PLoS One. 2013; 8(6):e65780.
        View in: PubMed PMC3680487
      23. Mabile L, Dalgleish R, Thorisson GA, Deschênes M, Hewitt R, Carpenter J, Bravo E, Filocamo M, Gourraud PA, Harris JR, Hofman P, Kauffmann F, Muñoz-Fernàndez MA, Pasterk M, Cambon-Thomsen A. Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience. 2013; 2(1):7.
        View in: PubMed PMC3655103
      24. Gourraud PA, Sdika M, Khankhanian P, Henry RG, Beheshtian A, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D, Baranzini SE. A genome-wide association study of brain lesion distribution in multiple sclerosis. Brain. 2013 Apr; 136(Pt 4):1012-24.
        View in: PubMed PMC3613709
      25. Escande H, Livideanu CB, Steiner A, Lahfa M, Marguery MC, Mazereeuw JH, Meyer N, Labadie FG, Aquilina C, Viraben R, Gourraud PA, Paul C. Incidence and risk factors for treatment failure with infliximab in psoriasis. J Eur Acad Dermatol Venereol. 2013 Oct; 27(10):1323-4.
        View in: PubMed
      26. Maiers M, Gragert L, Madbouly A, Steiner D, Marsh SG, Gourraud PA, Oudshoorn M, van der Zanden H, Schmidt AH, Pingel J, Hofmann J, Müller C, Eberhard HP. 16(th) IHIW: global analysis of registry HLA haplotypes from 20 million individuals: report from the IHIW Registry Diversity Group. Int J Immunogenet. 2013 Feb; 40(1):66-71.
        View in: PubMed PMC3561701
      27. McElroy JP, Krupp LB, Johnson BA, McCauley JL, Qi Z, Caillier SJ, Gourraud PA, Yu J, Nathanson L, Belman AL, Hauser SL, Waubant E, Hedges DJ, Oksenberg JR. Copy number variation in pediatric multiple sclerosis. Mult Scler. 2013 Jul; 19(8):1014-21.
        View in: PubMed
      28. Degos V, Gourraud PA, Tursis VT, Whelan R, Colonne C, Korinek AM, Clarençon F, Boch AL, Nouet A, Young WL, Apfel CC, Puybasset L. Elderly age as a prognostic marker of 1-year poor outcome for subarachnoid hemorrhage patients through its interaction with admission hydrocephalus. Anesthesiology. 2012 Dec; 117(6):1289-99.
        View in: PubMed
      29. von Büdingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, Cree BA, Gourraud PA, Schwartzburg A, Huerta G, Telman D, Sundar PD, Casey T, Cox DR, Hauser SL. B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest. 2012 Dec 3; 122(12):4533-43.
        View in: PubMed PMC3533544
      30. Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol. 2012 Aug; 72(2):234-40.
        View in: PubMed PMC3430977
      31. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev. 2012 Jul; 248(1):87-103.
        View in: PubMed
      32. Gourraud PA, Le Gall C, Puzenat E, Aubin F, Ortonne JP, Paul CF. Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis. J Invest Dermatol. 2012 Sep; 132(9):2171-5.
        View in: PubMed
      33. Bachet JB, Peuvrel L, Bachmeyer C, Reguiai Z, Gourraud PA, Bouché O, Ychou M, Bensadoun RJ, Dreno B, André T. Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review. Oncologist. 2012; 17(4):555-68.
        View in: PubMed PMC3336835
      34. Degos V, Apfel CC, Sanchez P, Colonne C, Renuit I, Clarençon F, Nouet A, Boch AL, Pourmohamad T, Kim H, Gourraud PA, Young WL, Puybasset L. An admission bioclinical score to predict 1-year outcomes in patients undergoing aneurysm coiling. Stroke. 2012 May; 43(5):1253-9.
        View in: PubMed
      35. Gourraud PA, Gilson L, Girard M, Peschanski M. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines. Stem Cells. 2012 Feb; 30(2):180-6.
        View in: PubMed
      36. Mack SJ, Gourraud PA, Single RM, Thomson G, Hollenbach JA. Analytical methods for immunogenetic population data. Methods Mol Biol. 2012; 882:215-44.
        View in: PubMed PMC4209087
      37. Gourraud PA, Hollenbach JA, Barnetche T, Single RM, Mack SJ. Standard methods for the management of immunogenetic data. Methods Mol Biol. 2012; 882:197-213.
        View in: PubMed PMC4209945
      38. Hollenbach JA, Mack SJ, Thomson G, Gourraud PA. Analytical methods for disease association studies with immunogenetic data. Methods Mol Biol. 2012; 882:245-66.
        View in: PubMed PMC4209949
      39. Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, Slager SL, Fredericksen ZS, Strong LC, Habermann TM, Link BK, Cerhan JR, Robison LL, Conti DV, Onel K. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood. 2012 Jan 12; 119(2):469-75.
        View in: PubMed PMC3257012
      40. Hollenbach JA, Mack SJ, Gourraud PA, Single RM, Maiers M, Middleton D, Thomson G, Marsh SG, Varney MD. A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. Tissue Antigens. 2011 Nov; 78(5):333-44.
        View in: PubMed PMC3636772
      41. Pouplard C, Gourraud PA, Meyer N, Livideanu CB, Lahfa M, Mazereeuw-Hautier J, Le Jeunne P, Sabatini AL, Paul C. Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis. Br J Dermatol. 2011 Dec; 165(6):1332-6.
        View in: PubMed
      42. Funk WD, Labat I, Sampathkumar J, Gourraud PA, Oksenberg JR, Rosler E, Steiger D, Sheibani N, Caillier S, Stache-Crain B, Johnson JA, Meisner L, Lacher MD, Chapman KB, Park MJ, Shin KJ, Drmanac R, West MD. Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes. Stem Cell Res. 2012 Mar; 8(2):154-64.
        View in: PubMed
      43. Lourari S, Paul C, Gouraud PA, Tavitian S, Viraben R, Leccia MT, Saiag P, Lebbe C, Meyer N. Sentinel lymph node biopsy for melanoma is becoming a consensus: a national survey of French centres involved in melanoma care in 2008. J Eur Acad Dermatol Venereol. 2012 Oct; 26(10):1230-5.
        View in: PubMed
      44. Textoris J, Loriod B, Benayoun L, Gourraud PA, Puthier D, Albanèse J, Mantz J, Martin C, Nguyen C, Leone M. An evaluation of the role of gene expression in the prediction and diagnosis of ventilator-associated pneumonia. Anesthesiology. 2011 Aug; 115(2):344-52.
        View in: PubMed
      45. Quintyn JC, Soler P, Fostier P, Gouraud PA, Lagarrigue J. [When the pupil becomes the teacher]. J Fr Ophtalmol. 2011 Oct; 34(8):521-5.
        View in: PubMed
      46. McElroy JP, Isobe N, Gourraud PA, Caillier SJ, Matsushita T, Kohriyama T, Miyamoto K, Nakatsuji Y, Miki T, Hauser SL, Oksenberg JR, Kira J. SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. Genes Immun. 2011 Oct; 12(7):523-30.
        View in: PubMed PMC3361962
      47. Gourraud PA. When is the absence of evidence, evidence of absence? Use of equivalence-based analyses in genetic epidemiology and a conclusion for the KIF1B rs10492972*C allelic association in multiple sclerosis. Genet Epidemiol. 2011 Sep; 35(6):568-71.
        View in: PubMed PMC3159840
      48. Laroumagne S, Salinas-Pineda A, Hermant C, Murris M, Gourraud PA, Do C, Segonds C, Didier A, Mazières J. [Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases]. Rev Mal Respir. 2011 Mar; 28(3):328-35.
        View in: PubMed
      49. Ducournau P, Gourraud PA, Rial-Sebbag E, Bulle A, Cambon-Thomsen A. [Direct-to-consumer genetic testing through Internet: marketing, ethical and social issues]. Med Sci (Paris). 2011 Jan; 27(1):95-102.
        View in: PubMed
      50. Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, Oksenberg JR. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol. 2011 Jan; 69(1):65-74.
        View in: PubMed PMC3511846
      51. Gourraud PA, Karaouni A, Woo JM, Schmidt T, Oksenberg JR, Hecht FM, Liegler TJ, Barbour JD. APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection. Hum Immunol. 2011 Mar; 72(3):207-12.
        View in: PubMed PMC3039048
      52. Quintyn JC, Fostier P, Gouraud PA, Payoux P, Lagarrigue J. [PowerVote: an evaluation tool]. J Fr Ophtalmol. 2011 Jan; 34(1):30-4.
        View in: PubMed
      53. Khankhanian P, Gourraud PA, Caillier SJ, Santaniello A, Hauser SL, Baranzini SE, Oksenberg JR. Genetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset. BMC Genomics. 2010; 11:626.
        View in: PubMed PMC3091764
      54. Gourraud PA, Meenagh A, Cambon-Thomsen A, Middleton D. Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics. 2010 Dec; 62(11-12):729-40.
        View in: PubMed PMC2978314
      55. Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2011 Mar; 78(2):179-83.
        View in: PubMed
      56. Cree BA, Rioux JD, McCauley JL, Gourraud PA, Goyette P, McElroy J, De Jager P, Santaniello A, Vyse TJ, Gregersen PK, Mirel D, Hafler DA, Haines JL, Pericak-Vance MA, Compston A, Sawcer SJ, Oksenberg JR, Hauser SL. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. PLoS One. 2010; 5(6):e11296.
        View in: PubMed PMC2892470
      57. McElroy JP, Cree BA, Caillier SJ, Gregersen PK, Herbert J, Khan OA, Freudenberg J, Lee A, Bridges SL, Hauser SL, Oksenberg JR, Gourraud PA. Refining the association of MHC with multiple sclerosis in African Americans. Hum Mol Genet. 2010 Aug 1; 19(15):3080-8.
        View in: PubMed PMC2901136
      58. Gomez-Brouchet A, Mourcin F, Gourraud PA, Bouvier C, De Pinieux G, Le Guelec S, Brousset P, Delisle MB, Schiff C. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma. Hum Pathol. 2010 Sep; 41(9):1220-30.
        View in: PubMed
      59. Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Maitre ML, Richard-Lallemand MA, Ortonne JP. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol. 2010 Apr; 24 Suppl 2:31-5.
        View in: PubMed
      60. Bronsard V, Paul C, Prey S, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol. 2010 Apr; 24 Suppl 2:17-22.
        View in: PubMed
      61. Paul C, Gourraud PA, Bronsard V, Prey S, Puzenat E, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP. Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. 2010 Apr; 24 Suppl 2:2-9.
        View in: PubMed
      62. Puzenat E, Bronsard V, Prey S, Gourraud PA, Aractingi S, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Paul C, Richard-Lallemand MA, Ortonne JP, Aubin F. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol. 2010 Apr; 24 Suppl 2:10-6.
        View in: PubMed
      63. Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol. 2010 Apr; 24 Suppl 2:23-30.
        View in: PubMed
      64. Sagnes-Raffy C, Gourraud PA, Hannon V, Bourrel R, Laffontan MA, Gaulene MC, Viala F, Clanet M. [Multiple sclerosis in Haute-Garonne: an important underestimation of case numbers]. Rev Epidemiol Sante Publique. 2010 Feb; 58(1):23-31.
        View in: PubMed
      65. Gourraud PA, Feolo M. The Babel Tower revisited: SNPs - Indels - CNVs. Confusion in naming sequence variant always rises from ashes. Tissue Antigens. 2010 Mar; 75(3):199-200.
        View in: PubMed
      66. Benouaich V, Soler P, Gourraud PA, Lopez S, Rousseau H, Marcheix B. Impact of meteorological conditions on the occurrence of acute type A aortic dissections. Interact Cardiovasc Thorac Surg. 2010 Mar; 10(3):403-6.
        View in: PubMed
      67. Pillaire MJ, Selves J, Gordien K, Gourraud PA, Gouraud PA, Gentil C, Danjoux M, Do C, Negre V, Bieth A, Guimbaud R, Trouche D, Pasero P, Méchali M, Hoffmann JS, Cazaux C. A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene. 2010 Feb 11; 29(6):876-87.
        View in: PubMed
      68. Paul CF, Gourraud PA. Cancer risk evaluation in psoriasis: in search of the Holy Grail? J Invest Dermatol. 2009 Nov; 129(11):2547-9.
        View in: PubMed
      69. Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA, Cross AH, De Jager PL, Gourraud PA, Cree BC, Hauser SL, Oksenberg JR. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun. 2010 Jun; 11(4):343-50.
        View in: PubMed PMC2880217
      70. Alvarez F, Meyer N, Gourraud PA, Paul C. CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals. Br J Dermatol. 2009 Nov; 161(5):1159-65.
        View in: PubMed
      71. Middleton D, Diler AS, Meenagh A, Sleator C, Gourraud PA. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. Tissue Antigens. 2009 Jun; 73(6):553-60.
        View in: PubMed
      72. Mattera L, Escaffit F, Pillaire MJ, Selves J, Tyteca S, Hoffmann JS, Gourraud PA, Chevillard-Briet M, Cazaux C, Trouche D. The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways. Oncogene. 2009 Mar 26; 28(12):1506-17.
        View in: PubMed
      73. Couturier N, Gourraud PA, Cournu-Rebeix I, Gout C, Bucciarelli F, Edan G, Babron MC, Clerget-Darpoux F, Clanet M, Fontaine B, Brassat D. IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. Eur J Hum Genet. 2009 Jun; 17(6):844-7.
        View in: PubMed PMC2947096
      74. Brondello JM, Pillaire MJ, Rodriguez C, Gourraud PA, Selves J, Cazaux C, Piette J. Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. Oncogene. 2008 Oct 16; 27(47):6093-101.
        View in: PubMed
      75. Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, Rouquet O, Dupuis E, Alric L, Vinel JP. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008 Jun; 27(12):1261-8.
        View in: PubMed
      76. Barnetche T, Constantin A, Cantagrel A, Cambon-Thomsen A, Gourraud PA. New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res Ther. 2008; 10(1):R26.
        View in: PubMed PMC2374469
      77. Middleton D, Meenagh A, Sleator C, Gourraud PA, Ayna T, Tozkir H, Köse AA, Azizleri G, Diler AS. No association of KIR genes with Behcet's disease. Tissue Antigens. 2007 Nov; 70(5):435-8.
        View in: PubMed
      78. Feve F, Cambon-Thomsen A, Eliaou JF, Gourraud PA, Raffoux C, Florens JP. [Economic evaluation of the organization of a registry of haematopoietic stem cell donors]. Rev Epidemiol Sante Publique. 2007 Aug; 55(4):275-84.
        View in: PubMed
      79. Gourraud PA, Hoffman D, Cambon-Thomsen A, Feolo M. 14th International HLA and Immunogenetics Workshop: report on mapping microsatellite markers in the major histocompatibility complex region. Tissue Antigens. 2007 Apr; 69 Suppl 1:206-9.
        View in: PubMed
      80. Gourraud PA, Cambon-Thomsen A, Dauber EM, Feolo M, Hansen J, Mickelson E, Single RM, Thomsen M, Mayr WR. Nomenclature for HLA microsatellites. Tissue Antigens. 2007 Apr; 69 Suppl 1:210-3.
        View in: PubMed
      81. Gourraud PA, Gagne K, Bignon JD, Cambon-Thomsen A, Middleton D. Preliminary analysis of a KIR haplotype estimation algorithm: a simulation study. Tissue Antigens. 2007 Apr; 69 Suppl 1:96-100.
        View in: PubMed
      82. Middleton D, Meenagh A, Gourraud PA. KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics. 2007 Feb; 59(2):145-58.
        View in: PubMed
      83. Gourraud PA, Dieudé P, Boyer JF, Nogueira L, Cambon-Thomsen A, Mazières B, Cornélis F, Serre G, Cantagrel A, Constantin A. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis. Arthritis Res Ther. 2007; 9(2):R27.
        View in: PubMed PMC1906795
      84. Barnetche T, Constantin A, Gourraud PA, Abbal M, Garnier JG, Cantagrel A, Cambon-Thomsen A. Microsatellite typing of the human leucocyte antigen region: analytical approach and contribution to rheumatoid arthritis immunogenetic studies. Tissue Antigens. 2006 Nov; 68(5):390-8.
        View in: PubMed
      85. Gourraud PA, Feolo M, Hoffman D, Helmberg W, Cambon-Thomsen A. The dbMHC microsatellite portal: a public resource for the storage and display of MHC microsatellite information. Tissue Antigens. 2006 May; 67(5):395-401.
        View in: PubMed
      86. Gourraud PA, Boyer JF, Barnetche T, Abbal M, Cambon-Thomsen A, Cantagrel A, Constantin A. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum. 2006 Feb; 54(2):593-9.
        View in: PubMed
      87. Denis L, Sivula J, Gourraud PA, Kerdudou N, Chout R, Ricard C, Moisan JP, Gagne K, Partanen J, Bignon JD. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion. Tissue Antigens. 2005 Oct; 66(4):267-76.
        View in: PubMed
      88. Gourraud PA, Barnetche T, Vidan-Jeras B, Cambon-Thomsen A. Introduction to statistical analysis of population data in immunogenetics. Transpl Immunol. 2005 Aug; 14(3-4):245-53.
        View in: PubMed
      89. Barnetche T, Gourraud PA, Cambon-Thomsen A. Strategies in analysis of the genetic component of multifactorial diseases; biostatistical aspects. Transpl Immunol. 2005 Aug; 14(3-4):255-66.
        View in: PubMed
      90. Gourraud PA, Lamiraux P, El-Kadhi N, Raffoux C, Cambon-Thomsen A. Inferred HLA haplotype information for donors from hematopoietic stem cells donor registries. Hum Immunol. 2005 May; 66(5):563-70.
        View in: PubMed
      91. Gourraud PA, Mano S, Barnetche T, Carrington M, Inoko H, Cambon-Thomsen A. Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis. Tissue Antigens. 2004 Nov; 64(5):543-55.
        View in: PubMed
      92. Gourraud PA, Génin E, Cambon-Thomsen A. Handling missing values in population data: consequences for maximum likelihood estimation of haplotype frequencies. Eur J Hum Genet. 2004 Oct; 12(10):805-12.
        View in: PubMed
      93. Cambon-Thomsen A, Ducournau P, Gourraud PA, Pontille D. Biobanks for genomics and genomics for biobanks. Comp Funct Genomics. 2003; 4(6):628-34.
        View in: PubMed PMC2447308
      Pierre-Antoine's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP